Identification of somatic copy number variations in plasma cell free DNA correlating with intrinsic resistances to EGFR targeted therapy in T790M negative non-small cell lung cancer.

Zhu, Lucheng; Liang, Jiafeng; Xia, Bing; Xu, Yasi; Qian, Ziliang; Ma, Shenglin; Zhang, Shirong

Zhu, Lucheng; Liang, Jiafeng; Xia, Bing; Xu, Yasi; Qian, Ziliang; Ma, Shenglin; Zhang, Shirong.

Afiliação

Zhu L; Center for Translational Medicine, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou 310006, China.
Liang J; Department of Oncology, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou 310006, China.
Xia B; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, China.
Xu Y; Center for Translational Medicine, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou 310006, China.
Qian Z; Department of Oncology, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou 310006, China.
Ma S; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, China.
Zhang S; Center for Translational Medicine, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou 310006, China.

J Thorac Dis ; 12(3): 883-892, 2020 Mar.

Article em En | MEDLINE | ID: mdl-32274156